JUPITER NEUROSCIENCES, INC. Interest Expense Nonoperating
JUPITER NEUROSCIENCES, INC. (JUNS) reported Interest Expense Nonoperating of $90.62 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-14
- JUPITER NEUROSCIENCES, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $90.62K, a 7883.96% increase year-over-year.
- JUPITER NEUROSCIENCES, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $118.64K, a 9553.70% increase year-over-year.
- JUPITER NEUROSCIENCES, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $62.46K, a 104.50% increase year-over-year.
- JUPITER NEUROSCIENCES, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $1.19K, a 98.89% decline year-over-year.
- JUPITER NEUROSCIENCES, INC. interest expense nonoperating for fiscal 2025 was $66.02K, a 73.42% decline from fiscal 2024.
- JUPITER NEUROSCIENCES, INC. interest expense nonoperating for fiscal 2024 was $248.37K, a 13.56% increase from fiscal 2023.
- JUPITER NEUROSCIENCES, INC. interest expense nonoperating for fiscal 2023 was $218.71K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $90.62K 10-Q · filed 2026-08-14 | $209.26K 10-Q · filed 2026-08-14 | $271.73K derived: sum of 3 quarters · filed 2026-08-14 | $272.92K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $118.64K 10-Q · filed 2026-05-14 | $181.11K derived: sum of 2 quarters · filed 2026-05-14 | $182.30K derived: sum of 3 quarters · filed 2026-05-14 | $183.44K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $62.46K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $63.66K derived: sum of 2 quarters · filed 2026-04-01 | $64.79K derived: sum of 3 quarters · filed 2026-08-14 | $66.02K 10-K · filed 2026-04-01 |
| 2025-09-30 | $1.19K 10-Q · filed 2025-11-14 | $2.33K derived: sum of 2 quarters · filed 2026-08-14 | $3.56K 10-Q · filed 2025-11-14 | $34.10K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $1.14K 10-Q · filed 2026-08-14 | $2.36K 10-Q · filed 2026-08-14 | $32.91K derived: sum of 3 quarters · filed 2026-08-14 | $140.29K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $1.23K 10-Q · filed 2026-05-14 | $31.77K derived: sum of 2 quarters · filed 2026-05-14 | $139.16K derived: sum of 3 quarters · filed 2026-05-14 | $195.45K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $30.55K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $137.93K derived: sum of 2 quarters · filed 2026-04-01 | $194.22K derived: sum of 3 quarters · filed 2026-04-01 | $248.37K 10-K · filed 2026-04-01 |
| 2024-09-30 | $107.38K 10-Q · filed 2025-11-14 | $163.67K derived: sum of 2 quarters · filed 2025-11-14 | $217.82K 10-Q · filed 2025-11-14 | $287.81K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $56.29K 10-Q · filed 2025-08-19 | $122.05K 10-Q · filed 2025-08-19 | $180.43K derived: sum of 3 quarters · filed 2025-08-19 | $261.04K derived: sum of 4 quarters · filed 2025-08-19 |
| 2024-03-31 | $65.76K 10-Q · filed 2025-05-15 | $124.14K derived: sum of 2 quarters · filed 2025-05-15 | $204.75K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $58.38K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $138.99K derived: sum of 2 quarters · filed 2025-03-28 | $218.71K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $80.61K 10-Q · filed 2024-12-23 | $160.32K 10-Q · filed 2024-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |